257 related articles for article (PubMed ID: 12831342)
1. The combination of olanzapine and fluoxetine in mood disorders.
Shelton RC
Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
Owen RT
Drugs Today (Barc); 2006 Mar; 42(3):185-92. PubMed ID: 16628260
[TBL] [Abstract][Full Text] [Related]
3. Influence of fluoxetine on olanzapine pharmacokinetics.
Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
5. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
Zhang W; Perry KW; Wong DT; Potts BD; Bao J; Tollefson GD; Bymaster FP
Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
[TBL] [Abstract][Full Text] [Related]
7. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
[TBL] [Abstract][Full Text] [Related]
8. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM; Cornelius V; Smith L; Young AH
Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine and olanzapine-fluoxetine combination treatment and bipolar I depression.
Williams AB; Adetunji BA
Arch Gen Psychiatry; 2005 Sep; 62(9):1052; author reply 1052. PubMed ID: 16143737
[No Abstract] [Full Text] [Related]
12. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
Shelton RC; Williamson DJ; Corya SA; Sanger TM; Van Campen LE; Case M; Briggs SD; Tollefson GD
J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
Potenza MN; Wasylink S; Epperson CN; McDougle CJ
Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
[No Abstract] [Full Text] [Related]
15. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
Croxtall JD; Scott LJ
CNS Drugs; 2010 Mar; 24(3):245-62. PubMed ID: 20155998
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine/fluoxetine combination for bipolar depression.
Shelton RC
Expert Rev Neurother; 2006 Jan; 6(1):33-9. PubMed ID: 16466309
[TBL] [Abstract][Full Text] [Related]
17. A novel augmentation strategy for treating resistant major depression.
Shelton RC; Tollefson GD; Tohen M; Stahl S; Gannon KS; Jacobs TG; Buras WR; Bymaster FP; Zhang W; Spencer KA; Feldman PD; Meltzer HY
Am J Psychiatry; 2001 Jan; 158(1):131-4. PubMed ID: 11136647
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
Deeks ED; Keating GM
Drugs; 2008; 68(8):1115-37. PubMed ID: 18484802
[TBL] [Abstract][Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
Amsterdam JD; Shults J
J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
